Holdings of VanEck Pharmaceutical ETF
VanEck ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 879.5M $ including 875.2M $ in equities, 99.5 %
- Positions
- 25 in 8 countries
- Top ten
- 72.7 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 148,335 | 177.9M $ | 20.23 % |
| 2 | Novartis AG | 596,253 | 93.4M $ | 10.63 % |
| 3 | Merck & Co Inc | 673,805 | 86.6M $ | 9.85 % |
| 4 | Novo Nordisk A/S | 984,355 | 47.2M $ | 5.37 % |
| 5 | AbbVie Inc | 159,879 | 40.2M $ | 4.57 % |
| 6 | Pfizer Inc | 1,646,085 | 39.6M $ | 4.51 % |
| 7 | Bristol-Myers Squibb Co | 682,122 | 39.3M $ | 4.47 % |
| 8 | GSK PLC | 741,178 | 38.9M $ | 4.42 % |
| 9 | Johnson & Johnson | 150,793 | 38.3M $ | 4.35 % |
| 10 | AstraZeneca PLC | 200,966 | 38.1M $ | 4.33 % |
| 11 | McKesson Corp | 47,981 | 36.3M $ | 4.12 % |
| 12 | SANOFI SA | 825,430 | 35.2M $ | 4.00 % |
| 13 | Cencora Inc | 104,297 | 29.5M $ | 3.36 % |
| 14 | Haleon PLC | 2,913,351 | 27.2M $ | 3.09 % |
| 15 | Teva Pharmaceutical Industries Ltd | 793,771 | 26.9M $ | 3.06 % |
| 16 | Takeda Pharmaceutical Co Ltd | 1,575,525 | 25.3M $ | 2.87 % |
| 17 | Zoetis Inc | 256,845 | 18.5M $ | 2.10 % |
| 18 | VIATRIS INC | 606,435 | 9.6M $ | 1.10 % |
| 19 | JAZZ PHARMACEUTICALS PLC | 39,436 | 9.5M $ | 1.08 % |
| 20 | Axsome Therapeutics Inc | 27,589 | 6.8M $ | 0.77 % |
| 21 | Corcept Therapeutics Inc | 50,964 | 4.4M $ | 0.50 % |
| 22 | ELANCO ANIMAL HEALTH INC | 126,222 | 3.1M $ | 0.35 % |
| 23 | Organon & Co | 148,817 | 2M $ | 0.23 % |
| 24 | Bausch Health Cos Inc | 174,617 | 860.9K $ | 0.10 % |
| 25 | Perrigo Co PLC | 50,862 | 528.5K $ | 0.06 % |
Sector breakdown
- Health care 91.1 %
- Consumer staples 3.1 %
- Unattributed 5.8 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 71.5 %
- United Kingdom 11.9 %
- Denmark 5.4 %
- France 4.0 %
- Israel 3.1 %
- Japan 2.9 %
- Ireland 1.1 %
- Canada 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 15 | 625.6M $ | 71.48 % |
| 2 | United Kingdom | 3 | 104.1M $ | 11.90 % |
| 3 | Denmark | 1 | 47.2M $ | 5.39 % |
| 4 | France | 1 | 35.2M $ | 4.02 % |
| 5 | Israel | 1 | 26.9M $ | 3.07 % |
| 6 | Japan | 1 | 25.3M $ | 2.89 % |
| 7 | Ireland | 2 | 10M $ | 1.15 % |
| 8 | Canada | 1 | 860.9K $ | 0.10 % |
Cite this page
Titelia. "Holdings of VanEck Pharmaceutical ETF". https://titelia.com/en/funds/S000034409